Professional
Added to YB: 2024-09-11
Pitch date: 2024-08-30
AVTR [bullish]
Avantor, Inc.
-56.42%
current return
Author Info
No bio for this author
Company Info
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Market Cap
$7.9B
Pitch Price
$25.63
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.06
P/E
-88.89
EV/Sales
1.74
Sector
Life Sciences Tools and Services
Category
growth
Broyhill Asset Management Portfolio Holding: Avantor, Inc.
AVTR: Shares rebounded 26% in July on strong earnings. Bioprocessing recovery expected, mid-high single-digit growth by year-end. 20% EBITDA margins targeted for 2025. Conservative guidance; potential upside as proprietary content grows & cost initiatives accelerate. Industry recovery could drive significant revisions.
Read full article (1 min)